Valuation: Jerusalem Pharmaceutical Co.

Market Cap 135M 135M 119M 111M 102M 190M 12.93B 195M 1.31B 513M 6.4B 507M 496M 22.12B P/E 2024
13.7x
P/E 2025 8.13x
Enterprise Value 124M 124M 109M 102M 93.42M 175M 11.89B 179M 1.21B 472M 5.88B 466M 456M 20.33B EV / Sales 2024
1.47x
EV / Sales 2025 1.47x
Free-Float
35.74%
Yield 2024
2.09%
Yield 2025 3.26%
Manager TitleAgeSince
Chief Executive Officer - 2013-06-30
Director of Finance/CFO - 2020-02-29
Chief Tech/Sci/R&D Officer - 1988-12-31
Director TitleAgeSince
Chairman 91 -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+1.43%+16.90%+74.77% 49.64B
-2.09%+3.84%+64.12%+113.57% 36.54B
+2.06%+2.92%-6.22%+25.17% 12.22B
+2.14%-1.78%+14.55%+75.28% 11.48B
+0.19%+1.35%+31.58%+132.30% 9.04B
-2.63%+3.94%+50.54%-4.41% 6.94B
+0.17%-0.68%+11.96%+33.49% 6.74B
+3.53%+0.87%+5.47%+183.15% 6.45B
+0.61%-6.24%-32.70%-1.66% 5.42B
Average +1.50%-0.77%+17.36%+70.19% 16.05B
Weighted average by Cap. +1.19%+0.44%+26.64%+80.28%

Financials

2024 2025
Net sales 39.82M 39.82M 34.99M 32.66M 29.97M 56.11M 3.81B 57.49M 387M 151M 1.89B 150M 146M 6.52B 48.95M 48.95M 43.01M 40.14M 36.84M 68.97M 4.69B 70.67M 476M 186M 2.32B 184M 180M 8.02B
Net income 5.04M 5.04M 4.43M 4.13M 3.79M 7.1M 483M 7.27M 49M 19.16M 239M 18.91M 18.5M 825M 10.18M 10.18M 8.95M 8.35M 7.67M 14.35M 975M 14.7M 99.04M 38.73M 483M 38.23M 37.4M 1.67B
Net Debt -10.32M -10.32M -9.07M -8.47M -7.77M -14.54M -989M -14.9M -100M -39.26M -489M -38.75M -37.91M -1.69B -10.9M -10.9M -9.57M -8.94M -8.2M -15.35M -1.04B -15.73M -106M -41.45M -516M -40.91M -40.02M -1.79B
Logo Jerusalem Pharmaceutical Co.
Jerusalem Pharmaceuticals Co Ltd (Al-Quds) is a Palestine-based public shareholding company engaged in the manufacture and trade of pharmaceutical, veterinary, detergent, and cosmetics products. Its product range spans the whole spectrum of ethical pharmaceuticals, as well as over the counter preparations and nutritional supplements. Its Products are presented in different dosage forms such as tablets, capsules, ampoules, granules and powders for suspensions, suspensions, syrups, lotions, powders, suppositories, ovules, creams, ointments, gels, emulgels, ear, eye and nose drops, solutions, mouth rinse and gargles. The Company also produces veterinary products including vials, powders, oral liquids and fodder additives such as multivitamins and multi-minerals. It also manufactures detergents and cosmetics under license from French companies. The Company operates three production facilities include Factory for General Production, Penicillin Factory and Cephalosporin Factory.
Employees
-